SCHEMBL7422960

SCHEMBL7422960

CCOC(=O)c1ccc(NC(=S)Nc2ccccn2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 1.00
HTT P42858 4/20 1.00
RAB9A P51151 6/20 0.78
SMN1; SMN2 Q16637 4/20 0.77
ALDH1A1 P00352 7/20 0.72
MAPT P10636 5/20 0.68
PKM P14618 2/20 0.68
NPSR1 Q6W5P4 2/20 0.68
TDP1 Q9NUW8 1/20 0.68
KDR P35968 1/20 0.63
LMNA P02545 2/20 0.63
KMT2A Q03164 4/20 0.61
MEN1 O00255 3/20 0.61
GAA P10253 2/20 0.61
KDM4E B2RXH2 2/20 0.61
HPGD P15428 1/20 0.58
ALOX12 P18054 1/20 0.58
NAMPT P43490 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5456563 0.81 RAB9A (0.75) NPC1HTTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL5239514 0.80 NPC1 (0.73) NPC1HTTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL6816396 0.79 RAB9A (0.71) NPC1HTTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL11173864 0.79 RAB9A (0.75) NPC1HTTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL4061488 0.78 NPC1 (0.64) NPC1HTTRAB9ASMN1; SMN2ALDH1A1
Methyl Alcohol SCHEMBL27776732 0.78 ALDH1A1 (0.97) NPC1HTTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL28464045 0.76 ALDH1A1 (1.00) NPC1HTTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL14096379 0.76 ALDH1A1 (0.78) NPC1HTTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL2634977 0.75 SMN1; SMN2 (0.87) NPC1HTTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL5457318 0.75 RAB9A (1.00) NPC1HTTRAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1133484-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS AstraZeneca AB (SE) 2001-09-19 EP disclosed
WO-2000005223-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS ASTRAZENECA AB (SE) 2000-02-03 WO disclosed